Ublituximab, a innovative antibody , offers a exciting step in the approach of immune-driven disease . Unlike many current therapies, ublituximab selectively targets and eliminates B cells, which are https://lfbr603255304.blognody.com/53374365/ublituximab-a-new-hope-for-autoimmune-disease